Chloroquine
Indications: This medicine is an antimalarial and amebicidal agent used to prevent and treat malaria . It may also be used to treat other conditions as determined by your doctor.
Directions for use: for prevention 125 ?750 mg one a week depending of body weight.
Pregnancy: may be used.
Side effects: include mild headache, nausea, diarrhoea, loss of appetite, stomach cramps, or itching. If they continue or are bothersome, check with your doctor. CHECK WITH YOUR DOCTOR AS SOON AS POSSIBLE if you experience vomiting, sensitivity to light, changes in vision or hearing, ringing in ears, sore throat or fever, personality changes, weakness, or seizures. If you notice other effects not listed above, contact your doctor, nurse, or pharmacist.
Chloroquine Resource: Identification of anti-malarial compounds as novel antagonists to chemokine receptor CXCR4 in pancreatic cancer cells. Kim J, Yip ML, Shen X, Li H, Hsin LY, Labarge S, Heinrich EL, Lee W, Lu J, Vaidehi N.PLoS One . 2012;7(2):e31004. Epub 2012 Feb 3Synthesis and Antitumoral Evaluation of 7-chloro-4-quinolinylhydrazones Derivatives. Montenegro RC, Lotufo LV, De Moraes MO, Pessoa Cdo O, Rodrigues FA, Bispo Mde L, Cardoso LN, Kaiser CR, De Souza MV.Med Chem . 2011 Nov 1;7(6):599-604pH-Sensitive Capsules as Intracellular Optical Reporters for Monitoring Lysosomal pH Changes Upon Stimulation. Rivera Gil P, Nazarenus M, Ashraf S, Parak WJ.Small . 2012 Feb 8. doi: 10.1002/smll.201101780. [Epub ahead of printComparative efficacy of Artemisinin Combination Therapies (ACTs) in P. falciparum malaria and polymorphism of PfATPase6, Pfcrt, Pfdhfr and Pfdhps genes in tea gardens of Jalpaiguri district, India. Saha P, Guha SK, Das S, Mullick S, Ganguly S, Biswas A, Bera DK, Chattopadhyay G, Das M, Kundu PK, Ray K, Maji AK.Antimicrob Agents Chemother . 2012 Feb 6. [Epub ahead of printPlasmodium falciparum: Assessment of Selectivity of Action of Chloroquine , Alchornea cordifolia, Ficus polita, and Other Drugs by a Tetrazolium-Based Colorimetric Assay. Ayisi NK, Appiah-Opong R, Gyan B, Bugyei K, Ekuban F.Malar Res Treat . 2011;2011:816250. Epub 2011 Dec 1Malaria treatment policy change and implementation: the case of Uganda. Nanyunja M, Nabyonga Orem J, Kato F, Kaggwa M, Katureebe C, Saweka J.Malar Res Treat . 2011;2011:683167. Epub 2011 Sep 19Pfcrt haplotypes and the evolutionary history of chloroquine -resistant Plasmodium falciparum. Awasthi G, Satya GB, Das A.Mem Inst Oswaldo Cruz . 2012 Feb;107(1):129-34Antiplasmodial and analgesic activities of Clausena anisata. Okokon JE, Etebong EO, Udobang JA, Essien GE.Asian Pac J Trop Med . 2012 Mar;5(3):214-9Defining Plasmodium falciparum Treatment in South West Asia: A Randomized Trial Comparing Artesunate or Primaquine Combined with Chloroquine or SP. Kolaczinski K, Leslie T, Ali I, Durrani N, Lee S, Barends M, Beshir K, Ord R, Hallett R, Rowland M.PLoS One . 2012;7(1):e28957. Epub 2012 Jan 31Different Patterns of pfcrt and pfmdr1 Polymorphisms in P. falciparum Isolates from Nigeria and Brazil: The Potential Role of Antimalarial Drug Selection Pressure. Gbotosho GO, Folarin OA, Bustamante C, Pereira da Silva LH, Mesquita E, Sowunmi A, Zalis MG, Oduola AM, Happi CT.Am J Trop Med Hyg . 2012 Feb;86(2):211-3Andrographolide sensitizes cisplatin-induced apoptosis via suppression of autophagosome-lysosome fusion in human cancer cells. Zhou J, Hu SE, Tan SH, Cao R, Chen Y, Xia D, Zhu X, Yang XF, Ong CN, Shen HM.Autophagy . 2012 Mar 1;8(3). [Epub ahead of printImproving cognitive outcome in cerebral malaria: insights from clinical and experimental research. de Mirandaa AS, Brant F, Machado FS, Rachid MA, Teixeira AL.Cent Nerv Syst Agents Med Chem . 2012 Jan 31. [Epub ahead of printHigh prevalence of pfcrt K76t mutants among Plasmodium falciparum isolates from Sabah, Malaysia. Norahmad NA, Abdullah NR, Yaccob N, Jelip J, Dony JF, Ruslan KF, Sulaiman LH, Sidek HM, Noedl H, Ismail Z.Southeast Asian J Trop Med Public Health . 2011 Nov;42(6):1322-6Influenza A/H1N1 vaccination of patients with SLE: can antimalarial drugs restore diminished response under immunosuppressive therapy? Borba EF, Saad CG, Pasoto SG, Calich AL, Aikawa NE, Ribeiro AC, Moraes JC, Leon EP, Costa LP, Guedes LK, Silva CA, Goncalves CR, Fuller R, Oliveira SA, Ishida MA, Precioso AR, Bonfa E.Rheumatology (Oxford) . 2012 Jan 31. [Epub ahead of printIn vivo sensitivity monitoring of chloroquine for the treatment of uncomplicated vivax malaria in four bordered provinces of Thailand during 2009-2010. Congpuon K, Satimai W, Sujariyakul A, Intanakom S, Harnpitakpong W, Pranuth Y, Cholpol S, Bualombai P.J Vector Borne Dis . 2011 Dec;48(4):190-6Effects of the antimalarial drugs ferroquine and artesunate on Plasmodium yoelii yoelii gametocytegenesis and vectorial transmission. Mustfa K, Landau I, Chabaud AG, Chavatte JM, Chandenier J, Duong TH, Richard-Lenoble D.Sante . 2011 Jul-Sep;21(3):133-42Biodegradable cyclen-based linear and cross-linked polymers as non-viral gene vectors. Li S, Wang Y, Wang S, Zhang J, Wu SF, Wang BL, Zhu W, Yu XQ.Bioorg Med Chem . 2012 Feb 15;20(4):1380-7. Epub 2012 Jan 18The combination of chloroquine and minocycline, a therapeutic option in cerebrospinal infection of Whipple's disease refractory to treatment with ceftriaxone, meropenem and co-trimoxazole. Feurle GE, Moos V, Schneider T, Fenollar F, Raoult D.J Antimicrob Chemother . 2012 Jan 27. [Epub ahead of print] No abstract available.[Ocular and cardiac toxicity by chloroquine ]. Gentille Lorente DI.Rev Med Chil . 2011 Oct;139(10):1384-6. Epub 2012 Jan 3. Spanish. No abstract available.Ascites due to lupus peritonitis: a rare form of onset of systemic lupus erythematosus. Pott JĂșnior H, Amate Neto A, Teixeira MA, Provenza JR.Rev Bras Reumatol . 2012 Feb;52(1):116-119. English, Portuguese.First
1
2
3
4
5
6
7
8
9
Next
Last 883/17657
Jump:
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668
669
670
671
672
673
674
675
676
677
678
679
680
681
682
683
684
685
686
687
688
689
690
691
692
693
694
695
696
697
698
699
700
701
702
703
704
705
706
707
708
709
710
711
712
713
714
715
716
717
718
719
720
721
722
723
724
725
726
727
728
729
730
731
732
733
734
735
736
737
738
739
740
741
742
743
744
745
746
747
748
749
750
751
752
753
754
755
756
757
758
759
760
761
762
763
764
765
766
767
768
769
770
771
772
773
774
775
776
777
778
779
780
781
782
783
784
785
786
787
788
789
790
791
792
793
794
795
796
797
798
799
800
801
802
803
804
805
806
807
808
809
810
811
812
813
814
815
816
817
818
819
820
821
822
823
824
825
826
827
828
829
830
831
832
833
834
835
836
837
838
839
840
841
842
843
844
845
846
847
848
849
850
851
852
853
854
855
856
857
858
859
860
861
862
863
864
865
866
867
868
869
870
871
872
873
874
875
876
877
878
879
880
881
882
883
Back to list of medicine Home
Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News TraveldoctorOnline 2001 Disclaimer webmaster
The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment. All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.